Onzigolide

N/A

Report date: 2025/05/29 15:39:49
NME

Base Information

Drug NameOnzigolide
Drug Alias NameDopastatinTBR-760BIM-23A760
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor 5 agonistsDopamine D2 receptor agonistsSomatostatin receptor 2 agonists
TargetsSomatostatin receptor 5Dopamine D2 receptorSomatostatin receptor 2
Therapy Area/IndicationsAcromegalyPituitary NeoplasmsAdenoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[23] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsenTiburio Therapeutics
Active IndicationsN/A
Inactive IndicationsAcromegalyPituitary NeoplasmsAdenoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A